Patents by Inventor Martin Sumner-Smith

Martin Sumner-Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8933039
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: January 13, 2015
    Assignees: NPS Pharmaceuticals, Inc., 1149336 Ontario Inc.
    Inventors: Daniel J Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 8880461
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: November 4, 2014
    Assignee: Open Text S.A.
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, Jr., Cheryl Lynne McKinnon, Florian Müller, Martin Sumner-Smith, Matthew David George Timmermans
  • Patent number: 8846625
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: September 30, 2014
    Assignee: 1149336 Ontario Inc.
    Inventors: Daniel J Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 8464206
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: June 11, 2013
    Assignee: Open Text S.A.
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, Jr., Cheryl Lynne McKinnon, Florian Müller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20110246444
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Application
    Filed: June 6, 2011
    Publication date: October 6, 2011
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, JR., Cheryl Lynne McKinnon, Florian Müller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20110238650
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Application
    Filed: June 7, 2011
    Publication date: September 29, 2011
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, JR., Cheryl Lynne McKinnon, Florian Müller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20110238649
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Application
    Filed: June 6, 2011
    Publication date: September 29, 2011
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, JR., Cheryl Lynne Mckinnon, Florian Müller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20110009320
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Application
    Filed: June 15, 2010
    Publication date: January 13, 2011
    Applicant: NPS PHARMACEUTICALS, INC.
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 7781401
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Grant
    Filed: November 14, 2002
    Date of Patent: August 24, 2010
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Publication number: 20090254422
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Application
    Filed: October 22, 2008
    Publication date: October 8, 2009
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, JR., Cheryl Lynne McKinnon, Florian Muller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20090249446
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Application
    Filed: October 22, 2008
    Publication date: October 1, 2009
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, JR., Cheryl Lynne Mckinnon, Florian Muller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20090249290
    Abstract: A method and system for providing a consistent flow documents and data content across different organizational units of a company or agency where the documents and data come from different enterprise systems and data stores but are related to linked processes that share models for organizing the content in the business context and in a format that enables a user to relate the content to the process step or steps they are performing. The system includes a network service that enables a configuration utility to automatically discover the objects and metadata and provides for a mapping of selected fields of the metadata to regions displayed in the user interface view with provision for filtering the data by mapping selected fields to a user input form. Thereby, a business analyst can create solutions without writing and maintaining complex program logic for each combination of presentation environment, enterprise system and data store.
    Type: Application
    Filed: October 22, 2008
    Publication date: October 1, 2009
    Inventors: Paul Thomas Jenkins, Daniel Wray Barkley, Robert W. Boender, Adam Murray Howatson, Willard Carter Morton, JR., Cheryl Lynne McKinnon, Florian Muller, Martin Sumner-Smith, Matthew David George Timmermans
  • Publication number: 20030162703
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Application
    Filed: November 14, 2002
    Publication date: August 28, 2003
    Applicant: NPS Allelix Corporation
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner Smith
  • Publication number: 20030109449
    Abstract: Antagonists of glucagon-like peptide 2, have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.
    Type: Application
    Filed: November 18, 2002
    Publication date: June 12, 2003
    Applicant: 1149336 Ontario Inc.
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 6489295
    Abstract: Antagonists of glucagon-like peptide 2, have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: December 3, 2002
    Assignee: 1149336 Ontario Inc.
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Publication number: 20010021767
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Application
    Filed: January 19, 2001
    Publication date: September 13, 2001
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 6184201
    Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
    Type: Grant
    Filed: April 8, 1997
    Date of Patent: February 6, 2001
    Assignee: NPS Allelix Corp.
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 5994500
    Abstract: Antagonists of glucagon-like peptide 2, have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.
    Type: Grant
    Filed: July 19, 1996
    Date of Patent: November 30, 1999
    Assignee: 1149336 Ontario Inc.
    Inventors: Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith
  • Patent number: 5831001
    Abstract: Described herein are oligopeptides useful to inhibit replication of herpesviruses, especially herpes simplex viruses. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 5 uM concentration, exhibits greater than 95% inhibition of HSV-1 replication, in a standard assay.
    Type: Grant
    Filed: January 26, 1995
    Date of Patent: November 3, 1998
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Michael Twist, Richard W. Barnett, Lorne S. Reid, Martin Sumner-Smith
  • Patent number: 5789531
    Abstract: Described herein are oligopeptides useful to inhibit replication in virally infected individuals. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 3 uM concentration, exhibits greater than 95% inhibition of HIV replication, in a standard assay.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 4, 1998
    Assignee: Allex Biopharmaceuticals, Inc.
    Inventors: Martin Sumner-Smith, Richard W. Barnett, Lorne S. Reid, Nahum Sonenberg